Menu

Blog

Feb 1, 2024

FDA Approves Toripalimab for Advanced Nasopharyngeal Cancer

Posted by in category: biotech/medical

Adding toripalimab (Loqtorzi) to chemo extended survival in people with nasopharyngeal cancer that returned after initial treatment or spread in the body.

Comments are closed.